Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029640 · ClinicalTrials.gov registry record
The Treatment of Children and Adolescents With Treatment-Resistant Depression
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 90
- Enrollment target
NCT00029640: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00029640 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029640 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study seeks to learn about brain function in adolescents with depression and to determine whether adding lithium carbonate to antidepressant medication can reduce depression in children and adolescents. Functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) will examine brain chemistry and function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-03 |
What the finished NCT00029640 record still lists
NCT00029640 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00029640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029640 about?
NCT00029640 is a clinical study titled "The Treatment of Children and Adolescents With Treatment-Resistant Depression". This study seeks to learn about brain function in adolescents with depression and to determine whether adding lithium carbonate to antidepressant medication can reduce depression in children and adolescents. Functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) will ...
What is the current status of trial NCT00029640?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2002-01. Estimated completion is 2004-03.
Who is sponsoring clinical trial NCT00029640?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia